Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Fiala

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
JCO Oncology Practice|March 6, 2024
Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple MyelomaMark A Fiala, Matthew R Leblanc, Kathryn W Coccia, et al.
Frontiers in Oncology|February 13, 2023
Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysisOwais Mian, Martine Puts, Arleigh McCurdy, et al.
JCO Clinical Cancer Informatics|July 7, 2025
Benefits, Problems, and Motivations for Using the Online Patient Portal in Adolescent Oncology: Interviews With Adolescents and ParentsBryan A Sisk, Stephanie Chen, Christine Bereitschaft, et al.
Leukemia & Lymphoma|February 5, 2015
Socioeconomic status is independently associated with overall survival in patients with multiple myelomaMark A Fiala, Joseph D Finney, Jingxia Liu, et al.
Annals of Hematology|March 5, 2020
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myelomaScott R Goldsmith, Mark A Fiala, Brandon Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple MyelomaMark A Fiala, Joseph D Finney, Keith E Stockerl-Goldstein, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2019
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple MyelomaArmin Ghobadi, Mark A Fiala, Michael Rettig, et al.
Journal of Geriatric Oncology|March 9, 2024
A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trialImran Haider, Gregory R Pond, Ruthanne Cameron, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 23, 2019
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass StudyScott R Goldsmith, Mark A Fiala, James Dukeman, et al.
Transplantation and Cellular Therapy|September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter TrialMichael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
JCO Oncology Practice|March 6, 2024
Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple MyelomaMark A Fiala, Matthew R Leblanc, Kathryn W Coccia, et al.
Frontiers in Oncology|February 13, 2023
Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysisOwais Mian, Martine Puts, Arleigh McCurdy, et al.
JCO Clinical Cancer Informatics|July 7, 2025
Benefits, Problems, and Motivations for Using the Online Patient Portal in Adolescent Oncology: Interviews With Adolescents and ParentsBryan A Sisk, Stephanie Chen, Christine Bereitschaft, et al.
Leukemia & Lymphoma|February 5, 2015
Socioeconomic status is independently associated with overall survival in patients with multiple myelomaMark A Fiala, Joseph D Finney, Jingxia Liu, et al.
Annals of Hematology|March 5, 2020
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myelomaScott R Goldsmith, Mark A Fiala, Brandon Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple MyelomaMark A Fiala, Joseph D Finney, Keith E Stockerl-Goldstein, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2019
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple MyelomaArmin Ghobadi, Mark A Fiala, Michael Rettig, et al.
Journal of Geriatric Oncology|March 9, 2024
A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trialImran Haider, Gregory R Pond, Ruthanne Cameron, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 23, 2019
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass StudyScott R Goldsmith, Mark A Fiala, James Dukeman, et al.
Transplantation and Cellular Therapy|September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter TrialMichael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
Pageof 8